Clinical Research Shows the Active Ingredient in Mikra’s Serenity Matches a Benzodiazepine in Effectiveness at Fighting Anxiety, Without Being Habit-Forming
TORONTO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, reports that European clinical research demonstrated that the active ingredient in Serenity, the newest product from its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. (“Mikra”), is equally effective as a prescription-only benzodiazepine in treating the symptoms of anxiety.
- This research was particularly noteworthy because benzodiazepines, while widely prescribed for anxiety, carry substantial risk of dependency and of seizures in case of withdrawal2.
- “It was this understanding that drove us to accelerate the launch of Serenity.
- With Lifeist's expertise with fragrant and flavorful botanicals, Serenity is poised to become the best tasting lavender oil extract supplement on the market.
- Plus, Serenity ships with a full 30-day supply in every bottle, as compared to the typical 7- or 14-day supply sold in competing lavender-based products.